Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Ueno

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Japanese Journal of Clinical Oncology|September 6, 2013
Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trialAkihiro Ito, Ichiro Shintaku, Makoto Satoh, et al.
International Journal of Cancer|May 9, 2008
Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancerSeiichi Saito, Yasuko Murayama, Yuzhuo Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group TrialAkihiro Ito, Ichiro Shintaku, Makoto Satoh, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Japanese Journal of Clinical Oncology|September 6, 2013
Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trialAkihiro Ito, Ichiro Shintaku, Makoto Satoh, et al.
International Journal of Cancer|May 9, 2008
Haptoglobin-beta chain defined by monoclonal antibody RM2 as a novel serum marker for prostate cancerSeiichi Saito, Yasuko Murayama, Yuzhuo Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group TrialAkihiro Ito, Ichiro Shintaku, Makoto Satoh, et al.
Pageof 2